Literature DB >> 26096614

ClC-1 mutations in myotonia congenita patients: insights into molecular gating mechanisms and genotype-phenotype correlation.

P Imbrici1, L Maggi2, G F Mangiatordi1, M M Dinardo1, C Altamura1, R Brugnoni2, D Alberga3, G Lauria Pinter4, G Ricci5, G Siciliano5, R Micheli6, G Annicchiarico7, G Lattanzi3, O Nicolotti1, L Morandi2, P Bernasconi2, J-F Desaphy1, R Mantegazza2, D Conte Camerino1.   

Abstract

KEY POINTS: Loss-of-function mutations of the skeletal muscle ClC-1 channel cause myotonia congenita with variable phenotypes. Using patch clamp we show that F484L, located in the conducting pore, probably induces mild dominant myotonia by right-shifting the slow gating of ClC-1 channel, without exerting a dominant-negative effect on the wild-type (WT) subunit. Molecular dynamics simulations suggest that F484L affects the slow gate by increasing the frequency and the stability of H-bond formation between E232 in helix F and Y578 in helix R. Three other myotonic ClC-1 mutations are shown to produce distinct effects on channel function: L198P shifts the slow gate to positive potentials, V640G reduces channel activity, while L628P displays a WT-like behaviour (electrophysiology data only). Our results provide novel insight into the molecular mechanisms underlying normal and altered ClC-1 function. ABSTRACT: Myotonia congenita is an inherited disease caused by loss-of-function mutations of the skeletal muscle ClC-1 chloride channel, characterized by impaired muscle relaxation after contraction and stiffness. In the present study, we provided an in-depth characterization of F484L, a mutation previously identified in dominant myotonia, in order to define the genotype-phenotype correlation, and to elucidate the contribution of this pore residue to the mechanisms of ClC-1 gating. Patch-clamp recordings showed that F484L reduced chloride currents at every tested potential and dramatically right-shifted the voltage dependence of slow gating, thus contributing to the mild clinical phenotype of affected heterozygote carriers. Unlike dominant mutations located at the dimer interface, no dominant-negative effect was observed when F484L mutant subunits were co-expressed with wild type. Molecular dynamics simulations further revealed that F484L affected the slow gate by increasing the frequency and stability of the H-bond formation between the pore residue E232 and the R helix residue Y578. In addition, using patch-clamp electrophysiology, we characterized three other myotonic ClC-1 mutations. We proved that the dominant L198P mutation in the channel pore also right-shifted the voltage dependence of slow gating, recapitulating mild myotonia. The recessive V640G mutant drastically reduced channel function, which probably accounts for myotonia. In contrast, the recessive L628P mutant produced currents very similar to wild type, suggesting that the occurrence of the compound truncating mutation (Q812X) or other muscle-specific mechanisms accounted for the severe symptoms observed in this family. Our results provide novel insight into the molecular mechanisms underlying normal and altered ClC-1 function.
© 2015 The Authors. The Journal of Physiology © 2015 The Physiological Society.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26096614      PMCID: PMC4594292          DOI: 10.1113/JP270358

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  58 in total

1.  Disease-causing mutations C277R and C277Y modify gating of human ClC-1 chloride channels in myotonia congenita.

Authors:  Sebastian Weinberger; Daniel Wojciechowski; Damien Sternberg; Frank Lehmann-Horn; Karin Jurkat-Rott; Toni Becher; Birgit Begemann; Christoph Fahlke; Martin Fischer
Journal:  J Physiol       Date:  2012-05-28       Impact factor: 5.182

2.  A new gating site in human aquaporin-4: Insights from molecular dynamics simulations.

Authors:  Domenico Alberga; Orazio Nicolotti; Gianluca Lattanzi; Grazia Paola Nicchia; Antonio Frigeri; Francesco Pisani; Valentina Benfenati; Giuseppe Felice Mangiatordi
Journal:  Biochim Biophys Acta       Date:  2014-08-19

3.  In vitro analysis of splice site mutations in the CLCN1 gene using the minigene assay.

Authors:  Gianna Ulzi; Valeria A Sansone; Francesca Magri; Stefania Corti; Nereo Bresolin; Giacomo P Comi; Sabrina Lucchiari
Journal:  Mol Biol Rep       Date:  2014-01-23       Impact factor: 2.316

4.  Mutations in the human skeletal muscle chloride channel gene (CLCN1) associated with dominant and recessive myotonia congenita.

Authors:  J Zhang; A L George; R C Griggs; G T Fouad; J Roberts; H Kwieciński; A M Connolly; L J Ptácek
Journal:  Neurology       Date:  1996-10       Impact factor: 9.910

5.  Intracellular β-nicotinamide adenine dinucleotide inhibits the skeletal muscle ClC-1 chloride channel.

Authors:  Brett Bennetts; Yawei Yu; Tsung-Yu Chen; Michael W Parker
Journal:  J Biol Chem       Date:  2012-06-11       Impact factor: 5.157

6.  Nondystrophic myotonia: challenges and future directions.

Authors:  Jaya R Trivedi; Stephen C Cannon; Robert C Griggs
Journal:  Exp Neurol       Date:  2013-12-18       Impact factor: 5.330

7.  Spectrum of mutations in the major human skeletal muscle chloride channel gene (CLCN1) leading to myotonia.

Authors:  C Meyer-Kleine; K Steinmeyer; K Ricker; T J Jentsch; M C Koch
Journal:  Am J Hum Genet       Date:  1995-12       Impact factor: 11.025

8.  Molecular basis of Thomsen's disease (autosomal dominant myotonia congenita).

Authors:  A L George; M A Crackower; J A Abdalla; A J Hudson; G C Ebers
Journal:  Nat Genet       Date:  1993-04       Impact factor: 38.330

9.  Functional and structural conservation of CBS domains from CLC chloride channels.

Authors:  Raúl Estévez; Michael Pusch; Carles Ferrer-Costa; Modesto Orozco; Thomas J Jentsch
Journal:  J Physiol       Date:  2004-01-14       Impact factor: 5.182

View more
  11 in total

1.  Understanding complexity of physiology by combined molecular simulations and experiments: anion channels as a proof of concept.

Authors:  Domenico Alberga; Giuseppe F Mangiatordi
Journal:  J Physiol       Date:  2016-06-01       Impact factor: 5.182

2.  Mapping ligand binding pockets in chloride ClC-1 channels through an integrated in silico and experimental approach using anthracene-9-carboxylic acid and niflumic acid.

Authors:  C Altamura; G F Mangiatordi; O Nicolotti; D Sahbani; A Farinato; F Leonetti; M R Carratù; D Conte; J-F Desaphy; P Imbrici
Journal:  Br J Pharmacol       Date:  2018-04-06       Impact factor: 8.739

3.  Translating genetic and functional data into clinical practice: a series of 223 families with myotonia.

Authors:  Karen Suetterlin; Emma Matthews; Richa Sud; Samuel McCall; Doreen Fialho; James Burge; Dipa Jayaseelan; Andrea Haworth; Mary G Sweeney; Dimitri M Kullmann; Stephanie Schorge; Michael G Hanna; Roope Männikkö
Journal:  Brain       Date:  2022-04-18       Impact factor: 15.255

4.  Multidisciplinary study of a new ClC-1 mutation causing myotonia congenita: a paradigm to understand and treat ion channelopathies.

Authors:  Paola Imbrici; Concetta Altamura; Giulia Maria Camerino; Giuseppe Felice Mangiatordi; Elena Conte; Lorenzo Maggi; Raffaella Brugnoni; Kejla Musaraj; Roberta Caloiero; Domenico Alberga; Renè Massimiliano Marsano; Giulia Ricci; Gabriele Siciliano; Orazio Nicolotti; Marina Mora; Pia Bernasconi; Jean-Francois Desaphy; Renato Mantegazza; Diana Conte Camerino
Journal:  FASEB J       Date:  2016-06-20       Impact factor: 5.191

5.  Census of halide-binding sites in protein structures.

Authors:  Rostislav K Skitchenko; Dmitrii Usoltsev; Mayya Uspenskaya; Andrey V Kajava; Albert Guskov
Journal:  Bioinformatics       Date:  2020-05-01       Impact factor: 6.937

6.  Divergent Cl- and H+ pathways underlie transport coupling and gating in CLC exchangers and channels.

Authors:  Lilia Leisle; Yanyan Xu; Eva Fortea; Sangyun Lee; Jason D Galpin; Malvin Vien; Christopher A Ahern; Alessio Accardi; Simon Bernèche
Journal:  Elife       Date:  2020-04-28       Impact factor: 8.140

Review 7.  An Up-to-Date Overview of the Complexity of Genotype-Phenotype Relationships in Myotonic Channelopathies.

Authors:  Fernando Morales; Michael Pusch
Journal:  Front Neurol       Date:  2020-01-17       Impact factor: 4.003

Review 8.  Therapeutic Targets in Amyotrophic Lateral Sclerosis: Focus on Ion Channels and Skeletal Muscle.

Authors:  Nancy Tarantino; Ileana Canfora; Giulia Maria Camerino; Sabata Pierno
Journal:  Cells       Date:  2022-01-25       Impact factor: 6.600

Review 9.  Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery.

Authors:  Paola Imbrici; Antonella Liantonio; Giulia M Camerino; Michela De Bellis; Claudia Camerino; Antonietta Mele; Arcangela Giustino; Sabata Pierno; Annamaria De Luca; Domenico Tricarico; Jean-Francois Desaphy; Diana Conte
Journal:  Front Pharmacol       Date:  2016-05-10       Impact factor: 5.810

Review 10.  Human Aquaporin-4 and Molecular Modeling: Historical Perspective and View to the Future.

Authors:  Giuseppe Felice Mangiatordi; Domenico Alberga; Daniela Trisciuzzi; Gianluca Lattanzi; Orazio Nicolotti
Journal:  Int J Mol Sci       Date:  2016-07-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.